Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1039 per EA under NDC 75834026701. Its NADAC has been published 207 times since Mar 24, 2021.
FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.
Strength
7.5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834026701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696FDA Approved
5/3/2018
TE Code
BX
On Market Since
2/15/2021
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 207 times since Mar 24, 2021, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1039 per EA |
|---|---|
| All-time high | $0.2986 (May 12, 2021) |
| All-time low | $0.0797 (Nov 20, 2024) |
| Median price | $0.1624 |
| Average price | $0.1738 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | Mar 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-29.8%
5Y
-55.8%
All
-63.6%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1039 per EA (NDC 75834026701), effective Mar 5, 2025.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 63.6%. It has been tracked across 207 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Mar 24, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2986 (May 12, 2021), with a median of $0.1624 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 75834026701) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.